Can UNH's Optum Rx Sustain Profit Growth as Prescription Volumes Fall?
Can UNH's Optum Rx Sustain Profit Growth as Prescription Volumes Fall? TradingView
Covered in this story
Analyst targets on UnitedHealth Group
- Wells Fargo: at $409 · target $487 by Oct 2027 via GuruFocus
- Mizuho: at $425 · target $500 by Oct 2027 via GuruFocus
- RBC Capital Markets: at $419 · target $498 by Oct 2027 · Outperform via Investing.com India
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $UNH yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on UnitedHealth Group →Dalsna Finance is currently tracking 46 stories mentioning UnitedHealth Group, the earliest published 19 Oct 2023.
Summary aggregated from TradingView's public RSS feed. The full reporting belongs to TradingView — please read it on their site.